Cidara Therapeutics Inc (CDTX)
13.43
+0.40
(+3.07%)
USD |
NASDAQ |
Nov 05, 16:00
13.43
0.00 (0.00%)
After-Hours: 19:16
Cidara Therapeutics Total Liabilities (Quarterly): 42.42M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 42.42M |
| March 31, 2024 | 70.50M |
| December 31, 2023 | 75.24M |
| September 30, 2023 | 55.43M |
| June 30, 2023 | 52.57M |
| March 31, 2023 | 54.90M |
| December 31, 2022 | 61.92M |
| September 30, 2022 | 57.79M |
| June 30, 2022 | 47.48M |
| March 31, 2022 | 50.34M |
| December 31, 2021 | 53.75M |
| September 30, 2021 | 52.36M |
| June 30, 2021 | 47.96M |
| March 31, 2021 | 52.32M |
| December 31, 2020 | 49.71M |
| September 30, 2020 | 34.12M |
| June 30, 2020 | 32.05M |
| March 31, 2020 | 30.34M |
| December 31, 2019 | 31.14M |
| September 30, 2019 | 32.73M |
| Date | Value |
|---|---|
| June 30, 2019 | 19.97M |
| March 31, 2019 | 20.45M |
| December 31, 2018 | 19.97M |
| September 30, 2018 | 22.88M |
| June 30, 2018 | 24.87M |
| March 31, 2018 | 19.33M |
| December 31, 2017 | 19.29M |
| September 30, 2017 | 16.86M |
| June 30, 2017 | 19.89M |
| March 31, 2017 | 16.77M |
| December 31, 2016 | 18.78M |
| September 30, 2016 | 8.317M |
| June 30, 2016 | 5.215M |
| March 31, 2016 | 4.145M |
| December 31, 2015 | 6.062M |
| September 30, 2015 | 4.363M |
| June 30, 2015 | 3.096M |
| March 31, 2015 | 78.31M |
| December 31, 2014 | 35.80M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
30.34M
Minimum
Mar 2020
75.24M
Maximum
Dec 2023
50.12M
Average
52.32M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| Arbutus Biopharma Corp | 37.59M |
| GlycoMimetics Inc | 4.356M |
| FibroGen Inc | 483.58M |
| Cue Biopharma Inc | 20.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 173.36M |
| Shareholders Equity (Quarterly) | 130.94M |
| Current Ratio | 4.253 |